Join PharmQD!
Become a member of our interactive community. Collaborate and network with your colleagues and trusted peers. Membership is free!
Communicate and Educate
Discuss new and important issues with your colleagues. Share your insights to help improve patient counseling.
Network With Peers
Join the conversation with trusted colleagues. Link up with professionals who share your ideas and insights.
Learn and Advance
Take free CE courses and rate courses for your peers. Find and apply for the newest jobs. Stay up-to-date on pharmacy news.
Unite
Share your experience with pharmacy students and technicians.
Create an account and receive access to the personalized box below, including your profile, bookmarks, friends, posts and more!
PharmNews
Featured News
ASCP Seeks Changes to DEA Regulations - 09.02.2010
The American Society of Consultant Pharmacists (ASCP) has asked the Drug Enforcement Administration (DEA) to consider changes to the Controlled Substances Act regulatory framework to improve timely access to controlled medications for residents in long-term care settings.
In a letter response to a June 29 DEA Request for Information Notice, “Dispensing of Controlled Substances to Residents at Long Term Care Facilities,” ASCP requests DEA clarify through formal rulemaking or policy statement the statutory definition of “agent” in relation to a physician who prescribes controlled medications to patients in long-term care facilities. The society recommends DEA recognize nurses as agents of physicians who prescribe controlled medications to patients in long-term care facilities and patients enrolled in Medicare- or state-certified hospice programs. ASCP also asks DEA to recognize patient charts containing controlled medication orders as valid prescriptions.More »
Featured News
Major Study Finds No Evidence That Statins Cause Cancer - 09.02.2010
In the largest and most reliable study of its type, the University of Oxford (UK) and the University of Sydney (Australia) have demonstrated that statin therapy is not a cause of increased cancer rates and deaths.
The conclusions of this study, presented at the European Society of Cardiology's Congress 2010 in Stockholm, will reassure the millions of people worldwide who are taking statins to lower cholesterol levels, and clarifies earlier research that had raised concerns of a causal link.More »
Featured News
COPD Drug Market Will Reach More Than $13 Billion in 2019 - 08.31.2010
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues finds that, through 2019, an expanding aging population and increases in diagnosis and drug treatment will fuel steady 4.6 percent annual growth in the chronic obstructive pulmonary disease (COPD) drug market.
The Pharmacor 2010 findings from the topic entitled Chronic Obstructive Pulmonary Disease reveal that the COPD drug market, which totaled nearly $8.4 billion in 2009, will reach more than $13 billion in 2019 in the United States, France, Germany, Italy, Spain, United Kingdom and Japan. The findings also reveal that the drug-treated COPD population will increase by nearly 6 million patients over the next decade. Although two maintenance therapies currently dominate the COPD market--GlaxoSmithKline's Advair/Seretide/Adoair and Boehringer Ingelheim/Pfizer's Spiriva--the near-term market will become fractured owing to the launch of new agents and generic erosion of key brands.More »
Featured News
Amphetamine Use Increases Risk of Aortic Tears in Young Adults - 08.31.2010
Young adults who abuse amphetamines may be at greater risk of suffering a tear in the main artery leading from the heart, UT Southwestern Medical Center researchers have found.
In the study, published in the August issue of American Heart Journal, researchers examined medical records from nearly 31 million people between 18 and 49 years old hospitalized from 1995 to 2007 and found that amphetamine abuse was associated with a threefold increase in the odds of aortic dissection.More »
Featured News
Decongestant Use in Pregnant Women Linked to Lower Risk of Preterm Birth - 08.31.2010
A new study led by Boston University School of Public Health (BUSPH) epidemiologists has found that women who took over-the-counter decongestants during their pregnancies are less likely to give birth prematurely.
Preterm birth -- deliveries at less than 37 weeks' gestation -- is the leading cause of infant morbidity and mortality in developed countries, but its causes remain largely unknown, said Rohini Hernandez, the study's lead author and a doctoral candidate in epidemiology at BUSPH. In the United States, the rate of preterm delivery has increased from 9.5 percent in 1981 to 12.3 percent in 2008.More »


